|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$6,875||Benefits minus costs||$21,310|
|Participants||$14,342||Benefit to cost ratio||$50.78|
|Others||$526||Chance the program will produce|
|Indirect||($4)||benefits greater than the costs||84 %|
|Net program cost||($428)|
|Benefits minus cost||$21,310|
|Detailed Monetary Benefit Estimates Per Participant|
|Benefits from changes to:1||Benefits to:|
|Labor market earnings associated with anxiety disorder||$6,450||$14,203||$0||$0||$20,654|
|Health care associated with anxiety disorder||$425||$138||$526||$210||$1,299|
|Adjustment for deadweight cost of program||$0||$0||$0||($214)||($214)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$1,319||2015||Present value of net program costs (in 2015 dollars)||($428)|
|Comparison costs||$814||2008||Cost range (+ or -)||10 %|
|Estimated Cumulative Net Benefits Over Time (Non-Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in non-discounted dollars to simplify the “break-even” point from a budgeting perspective. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
|Meta-Analysis of Program Effects|
|Outcomes measured||No. of effect sizes||Treatment N||Adjusted effect sizes (ES) and standard errors (SE) used in the benefit-cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
England, E.L., Herbert, J.D., Forman, E.M., Rabin, S.J., Juarascio, A., & Goldstein, S.P. (2012). Acceptance-based exposure therapy for public speaking anxiety. Journal of Contextual Behavioral Science, 1, 66-72.
Roemer, L., Orsillo, S.M., & Salters-Pedneault, K. (2008). Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: evaluation in a randomized controlled trial. Journal of Consulting and Clinical Psychology, 76 (6), 1083-9.
Craske, M.G., Niles, A.N., Burklund, L.J., Wolitzky-Taylor, K.B., Vilardaga, J.C., Arch, J.J., Saxbe, D.E., ... Lieberman, M.D. (2014). Randomized controlled trial of cognitive behavioral therapy and acceptance and commitment therapy for social phobia: outcomes and moderators. Journal of Consulting and Clinical Psychology, 82 (6), 1034-48.
Zargar, F., Asgharnejad, F.A.A., Atef-Vahid, M.K., Afshar, H., Maroofi, M., & Omranifard, V. (2012). Effect of acceptance-based behavior therapy on severity of symptoms, worry and quality of life in women with generalized anxiety disorder. Iranian Journal of Psychiatry and Behavioral Sciences, 6(2), 23-32.